Huda Zoghbi

Dr. Huda Y.
Zoghbi, MD, is a Chairman-Scientific Advisory Board at Cajal Therapeutics, an Independent Director at Regeneron Pharmaceuticals, Inc., an Investigator at Howard Hughes Medical Institute, Inc., a Professor-Pediatrics, Molecular & Human Genetics at Baylor College of Medicine, a Director-Texas Children's Neurological Research at Texas Children's Hospital, a Member at American Academy of Arts & Sciences, a Member at American Association for the Advancement of Science, a Member at National Academy of Inventors, a Member at National Academy of Medicine (United States), a Member at National Academy of Sciences, a President & Director at The McKnight Endowment Fund for Neuroscience and a Science Partner at The Column Group LLC.
She is on the Board of Directors at Regeneron Pharmaceuticals, Inc. and The McKnight Endowment Fund for Neuroscience.
Dr. Zoghbi was previously employed as a Founder by FORUM Pharmaceuticals, Inc. She received her undergraduate degree from American University of Beirut and a doctorate degree from Meharry Medical College.